A detailed history of Efg Asset Management (North America) Corp. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 45,968 shares of VERA stock, worth $1.96 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
45,968
Previous 31,444 46.19%
Holding current value
$1.96 Million
Previous $1.14 Million 78.63%
% of portfolio
0.35%
Previous 0.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$34.09 - $46.71 $495,123 - $678,416
14,524 Added 46.19%
45,968 $2.03 Million
Q2 2024

Jul 25, 2024

BUY
$33.72 - $48.82 $711,525 - $1.03 Million
21,101 Added 204.01%
31,444 $1.14 Million
Q1 2024

May 13, 2024

BUY
$14.91 - $49.14 $154,214 - $508,255
10,343 New
10,343 $445,000

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.15B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.